• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Catabasis Pharmaceuticals - Articles and news items

CAT-2054

Catabasis Pharmaceuticals announces preliminary Phase 1 data for hypercholesterolaemia product candidate CAT-2054

Industry news / 4 June 2015 / Victoria White

Catabasis has announced preliminary Phase 1 clinical trial data for CAT-2054 – its candidate for the potential treatment of hypercholesterolaemia…

 

Webinar: Use of MicroNIR to optimise fluid bed drying and to reduce waste at tablet compressionFIND OUT MORE
+ +